Combining proactive preparation with deep expertise in HTA dossier development, we support efficient delivery of JCA-ready submission packages.

The regulation on health technology assessment (Regulation (EU) 2021/2282) established a framework for joint scientific consultations (JSC) at EU level.

JSCs enable health technology developers (HTDs) to obtain scientific consultation during the planning of the clinical studies and clinical investigations of a health technology on the information and evidence needs for a subsequent Joint Clinical Assessment (JCA).